MedTrace Logo

Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer

NCT01551251 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 107

Last updated 2015-07-28

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of tumor associated macrophage (TAM) in advanced non-small cell lung cancer (NSCLC) patients on the treatment response and outcome of these subjects. Pathologic specimens from tissue bank will be stained by immunostaining methods with CD68 antibody. The clinical treatment response and outcomes will be analyzed between high or low TAM.

Conditions

  • Advanced Nonsmall Cell Lung Cancer

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • Fu-Tsai Chung, M.D. · Chang Gung Memorial Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01551251 on ClinicalTrials.gov